Advisornet Financial’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-1,200
Closed -$12.8K – 2439
2022
Q4
$12.8K Hold
1,200
– – ﹤0.01% 1223
2022
Q3
$12K Hold
1,200
– – ﹤0.01% 1283
2022
Q2
$17K Hold
1,200
– – ﹤0.01% 1185
2022
Q1
$31K Hold
1,200
– – ﹤0.01% 1117
2021
Q4
$48K Hold
1,200
– – ﹤0.01% 1026
2021
Q3
$60K Buy
+1,200
New +$65.4K ﹤0.01% 943

Other funds holding HCAT

Advisornet Financial's HCAT Position: Q1 2023 in Review

Advisornet Financial sold out of Health Catalyst (HCAT) in Q1 2023, closing a stake of 1,200 shares — an estimated $12.8K sold.

Advisornet Financial first reported a position in HCAT in Q3 2021 and held it in 6 quarters. The position peaked at $60K in Q3 2021. 161 funds tracked by Wall St. Rank hold HCAT as of Q1 2023.

  • Advisornet Financial reported no remaining Health Catalyst position as of Q1 2023 after selling out during the quarter.
  • Advisornet Financial sold 1,200 Health Catalyst shares in Q1 2023, an estimated $12.8K.
  • Advisornet Financial first reported a position in Health Catalyst in Q3 2021 and held it in 6 quarters.
  • Advisornet Financial's Health Catalyst position peaked at $60K in Q3 2021.
  • 161 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2023.

Based on Advisornet Financial's 13F filing for Q1 2023, filed 28 Apr 2023.